Log In
Print
BCIQ
Print
Print this Print this
 

NKTR-171

  Manage Alerts
Collapse Summary General Information
Company Nektar Therapeutics
DescriptionSodium channel blocker
Molecular Target Sodium channel
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationPain
Indication DetailsTreat neuropathic pain
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today